These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27601344)

  • 21. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
    Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
    Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
    Walz PH; Riddell KP; Newcomer BW; Neill JD; Falkenberg SM; Cortese VS; Scruggs DW; Short TH
    Vaccine; 2018 Jun; 36(26):3853-3860. PubMed ID: 29699786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
    Xue W; Mattick D; Smith L; Umbaugh J; Trigo E
    Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do modified live virus vaccines against bovine viral diarrhea induce fetal cross-protection against HoBi-like Pestivirus?
    Nardelli S; Decaro N; Belfanti I; Lucente MS; Giammarioli M; Mion M; Lucchese L; Martini M; Cecchinato M; Schiavo M; Occhiogrosso L; Lora M; Buonavoglia C; Ceglie L
    Vet Microbiol; 2021 Sep; 260():109178. PubMed ID: 34330023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
    Platt R; Coutu C; Meinert T; Roth JA
    Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
    Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
    Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring bovine viral diarrhea virus vaccine response: using a commercially available ELISA as a surrogate for serum neutralization assays.
    Gonda MG; Fang X; Perry GA; Maltecca C
    Vaccine; 2012 Oct; 30(46):6559-63. PubMed ID: 22944626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to bovine viral diarrhea virus (BVDV) vaccines detecting antibodies to BVDV subtypes 1a, 1b, 2a, and 2c.
    Fulton RW; Cook BJ; Payton ME; Burge LJ; Step DL
    Vaccine; 2020 May; 38(24):4032-4037. PubMed ID: 32336600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
    Fairbanks KK; Rinehart CL; Ohnesorge WC; Loughin MM; Chase CC
    J Am Vet Med Assoc; 2004 Dec; 225(12):1898-904. PubMed ID: 15643841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
    Ficken MD; Ellsworth MA; Tucker CM
    Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
    Fairbanks K; Schnackel J; Chase CC
    Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal immune response in newborn Holstein calves that had maternally derived antibodies and were vaccinated with an intranasal multivalent modified-live virus vaccine.
    Hill KL; Hunsaker BD; Townsend HG; van Drunen Littel-van den Hurk S; Griebel PJ
    J Am Vet Med Assoc; 2012 May; 240(10):1231-40. PubMed ID: 22559114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
    Brock KV; McCarty K; Chase CC; Harland R
    Vet Ther; 2006; 7(1):27-34. PubMed ID: 16598681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
    Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
    Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge.
    Platt R; Widel PW; Kesl LD; Roth JA
    Vaccine; 2009 Jul; 27(33):4508-19. PubMed ID: 19446589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of modified-live and inactivated vaccines in boosting disease-sparing responses to bovine viral diarrhea virus challenge in neonatally mucosally primed weanling beef calves.
    Erickson N; Godson D; Gow S; Lacoste S; Waldner C; Ellis J
    Can Vet J; 2023 Apr; 64(4):321-328. PubMed ID: 37008637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.